SCHEMBL4547006

SCHEMBL4547006

Fc1cccc(-c2cc(-c3cccc(F)c3)nc(-c3cccc(F)c3)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
MEN1 O00255 1/20 0.55
MAPT P10636 1/20 0.55
KMT2A Q03164 1/20 0.55
IDO1 P14902 2/20 0.52
TAAR1 Q96RJ0 2/20 0.50
ESR2 Q92731 1/20 0.50
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
KMO O15229 2/20 0.47
ACHE P22303 2/20 0.47
BCHE P06276 1/20 0.47
KDM5B Q9UGL1 1/20 0.46
MAP4K4 O95819 1/20 0.46
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CYP17A1 P05093 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29287262 0.89 MGAM (0.51) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29470232 0.86 MEN1 (0.58) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL198702 0.81 TAAR1 (0.68) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29473435 0.80 ACHE (0.50) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL28130409 0.79 MAPKAPK2 (0.55) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29287261 0.79 PTGS2 (0.46) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29287259 0.79 KDM4E (0.47) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL17082215 0.79 TAAR1 (0.60) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL29628985 0.78 TAAR1 (0.65) KDM4EMEN1MAPTKMT2AIDO1
SCHEMBL16605626 0.78 TAAR1 (0.65) KDM4EMEN1MAPTKMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 2187/4885MEN1 1984/4885MAPT 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.